Kathy Q Cai

SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS).

D. Flieder, M. von Mehren, E. Handorf, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.